Gentile S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf
2005; 28: 137–52.
Deering S. Eating disorders: recognition, evaluation, and implications for obstetrician/gynecologists (1). Prim Care Update Ob Gyns
2001; 8: 31–5.
Lancet. Better news on population. Lancet
1992; 339: 1600.
Zuckerman B, Amaro H, Bauchner H, Cabral H. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol
1989; 160: 1107–11.
Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA
2006; 295: 499–507.
Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol
2007; 80: 18–27.
Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med
2006; 354: 579–87.
Kallen B, Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol
2006; 21: 221–2.
Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA
1998; 279: 609–10.
Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Horn M, Koren G. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA
1993; 269: 2246–8.
Goldstein DJ, Corbin LA, Sundell KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol
1997; 89: 713–8.
Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf
2005; 14: 823–7.
Kinney DK, Yurgelun-Todd DA, Levy DL, Medoff D, Lajonchere CM, Radford-Paregol M. Obstetrical complications in patients with bipolar disorder and their siblings. Psychiatry Res
1993; 48: 47–56.
Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol
1992; 45: 1093–9.
Orr ST, Miller CA. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev
1995; 17: 165–71.
Franko DL, Blais MA, Becker AE, Delinsky SS, Greenwood DN, Flores AT, Ekeblad ER, Eddy KT, Herzog DB. Pregnancy complications and neonatal outcomes in women with eating disorders. Am J Psychiatry
2001; 158: 1461–6.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9).
Régie de l'Assurance Maladie du Québec. Annual Statistics.
Government of Quebec, 1997.
Ramos E, Oraichi D, Rey E, Blais L, Berard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG
2007; 114: 1055–64.
Ofori B, Rey E, Berard A. Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol
2007; 64: 496–509.
Martel MJ, Rey E, Beauchesne MF, Perreault S, Lefebvre G, Forget A, Blais L. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ
2005; 330: 230.
Blais L, Beauchesne MF, Rey E, Malo JL, Forget A. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma. Thorax
2007; 62: 320–8.
Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol
1995; 48: 999–1009.
Levy AR, Mayo NE, Grimard G. Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981–1992. Am J Epidemiol
1995; 142: 428–36.
Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med
1996; 335: 1010–5.
Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A. Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health
2005; 8: 214–20.
Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med
2007; 356: 2675–83.
Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med
2007; 356: 2684–92.
Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol
1982; 116: 114–22.
Tilley BC, Barnes AB, Bergstralh E, Labarthe D, Noller KL, Colton T, Adam E. A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol
1985; 121: 269–81.
Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci
1991; 13: 91–6.
West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol
1995; 142: 1103–12.
De Jong van den Berg LT, Feenstra N, Sorensen HT, Cornel MC. Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. European Medicine and Pregnancy Group. Teratology
1999; 60: 33–6.
Banhidy F, Lowry RB, Czeizel AE. Risk and benefit of drug use during pregnancy. Int J Med Sci
2005; 2: 100–6.
International Clearinghouse for Birth Defects Monitoring Systems. Annual Report.
Murphy JM, Olivier DC, Monson RR, Sobol AM, Federman EB, Leighton AH. Depression and anxiety in relation to social status. A prospective epidemiologic study. Arch Gen Psychiatry
1991; 48: 223–9.